Virtual Epilepsy Academy (VIREPA)

Application for January 2019 courses is now open

The International League Against Epilepsy’s Virtual Epilepsy Academy (VIREPA) provides a variety of online courses about the diagnosis, treatment and management of epilepsy. The internet-based, e-moderated courses are highly interactive and involve a great deal of collaboration and discussion among students and faculty. The courses are primarily intended for neurologists, pediatric neurologists and pediatricians, neuropsychiatrists and neuropsychologists, epilepsy nurses and nurse practitioners dealing with patients with epilepsy. However, some courses are appropriate for neurophysiologists and basic scientists including geneticists, physiologists and neuroscientists, who are dealing with patients with epilepsy.

Frequently Asked Questions about VIREPA courses

Course Details

For details about the courses, fees, bursaries, and prerequisites, select the appropriate link.

EEG in the Diagnosis & Management of Epilepsy – Pediatric
Course DetailsSchedule

Epilepsy & Sleep – Advanced
Course DetailsSchedule

For questions, please contact ILAE VIREPA staff at courses@ilae.org

Application for the courses below is closed but will reopen in June 2019:

EEG in the Diagnosis & Management of Epilepsy - Basic
Course DetailsSchedule

EEG in the diagnosis & management of epilepsy – Advanced
Course Details Schedule

 

Application Process

Please note that it is necessary to submit all required documents for your course at the time you submit your VIREPA application. Though it is important to keep the application deadline in mind, do not submit your application until you are able to upload all required documents.

When the application deadline has been reached, the Course Directors will review each application for quality and completeness. Incomplete applications will not be considered. Applicants will be informed of the outcome of their application within 3-4 weeks after the application deadline.

To apply for a VIREPA course now, click here.

Bursary Application Requirements

Submission of a letter of recommendation from the bursary applicant’s current workplace or from the leadership of the local ILAE Chapter or Regional Commission stating the expected benefit to the epilepsy care and development in the bursary applicant’s community specific to the VIREPA course for which application is being made is required.

In case such evidence cannot be submitted, a personal letter of motivation is required outlining the benefit the bursary candidate expects for his/her daily practice and professional career specific to the VIREPA course for which application is being made.

Please note that this requirement (letter of recommendation OR personal letter of motivation) is mandatory and is an important part of the decision-making process for the granting of any bursary. It is also important to note that dropping out of a course, or having limited participation in one, may impact future decisions about bursary eligibility.

Only one ILAE bursary per year per person is possible. Bursaries will be partial bursaries involving partial payment. Partial bursaries will only be available for participants living in countries with low and lower middle income. See categories according to the statistics of the World Bank.

Michael Foundation Support for European Applicants Only

European applicants who cannot afford the full registration fee may apply for support by the Michael Foundation, Germany. The Foundation is willing to cover 50% of the registration fee for a limited number of participants. For more information, please see the Michael Foundation website. If you are interested, please contact the Michael Foundation (post@stiftung-michael.de) at the same time and in parallel to your course application. The Michael Foundation support is only given on the condition that the course application is accepted.

To apply for a VIREPA course now, click here.

Photos from the VIREPA Luncheon at the 32nd IEC in Barcelona, September 2017

See more VIREPA photos in the photo galleries from the 32nd International Epilepsy Congress